- Home
- GH vs VFC Comparison
GH vs VFC Comparison
Compare GH & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- VFC
- Stock Information
- Founded
- GH 2011
- VFC 1899
- Country
- GH United States
- VFC United States
- Employees
- GH N/A
- VFC N/A
- Industry
- GH Medical Specialities
- VFC Apparel
- Sector
- GH Health Care
- VFC Consumer Discretionary
- Exchange
- GH Nasdaq
- VFC Nasdaq
- Market Cap
- GH 6.1B
- VFC 6.5B
- IPO Year
- GH 2018
- VFC N/A
- Fundamental
- Price
- GH $40.64
- VFC $16.30
- Analyst Decision
- GH Strong Buy
- VFC Buy
- Analyst Count
- GH 20
- VFC 19
- Target Price
- GH $48.40
- VFC $23.42
- AVG Volume (30 Days)
- GH 2.6M
- VFC 6.4M
- Earning Date
- GH 05-08-2025
- VFC 01-29-2025
- Dividend Yield
- GH N/A
- VFC 2.21%
- EPS Growth
- GH N/A
- VFC N/A
- EPS
- GH N/A
- VFC N/A
- Revenue
- GH $739,016,000.00
- VFC $10,147,207,000.00
- Revenue This Year
- GH $19.11
- VFC N/A
- Revenue Next Year
- GH $21.44
- VFC $1.62
- P/E Ratio
- GH N/A
- VFC N/A
- Revenue Growth
- GH 31.04
- VFC N/A
- 52 Week Low
- GH $15.81
- VFC $11.00
- 52 Week High
- GH $50.89
- VFC $29.02
- Technical
- Relative Strength Index (RSI)
- GH 46.62
- VFC 20.99
- Support Level
- GH $34.88
- VFC $16.64
- Resistance Level
- GH $45.00
- VFC $17.92
- Average True Range (ATR)
- GH 3.11
- VFC 1.29
- MACD
- GH -0.28
- VFC -0.97
- Stochastic Oscillator
- GH 51.89
- VFC 2.13
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About VFC V.F. Corporation
VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 11 brands includes Vans, The North Face, Timberland, Altra, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.